Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 225Ac-SSO110 (satoreotide) for the treatment of patients with Small Cell Lung Cancer (SCLC).
Public Health Experts Decry Louisiana’s Ban on Vaccine Promotion
In the wake of state public health officials barring promotion of certain vaccines — as is occurring in Louisiana — physicians and medical societies must
December 21, 2024